Abstract
Early onset of Action and Sustained Efficacy of MRI Outcomes during Cladribine Tablets Treatment in Highly Active Relapsing Multiple Sclerosis: Results of the 2-Year MAGNIFY-MS Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have